Skip to content

Research on the Protective Effect and Underlying Mechanism of ciprofol preconditioning on hepatic ischemia-reperfusion injury

Research on the Protective Effect and Underlying Mechanism of ciprofol preconditioning on hepatic ischemia-reperfusion injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108096
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic ischemia-reperfusion injury

Interventions

Ciprofol pre-treatment group:General anesthesia was induced and maintained with conventional anesthetic drugs. Thirty minutes before reperfusion, 0.4 mg/kg of ciprofol was intravenously infused over 3
Control group:Receive only conventional anesthesia with placebo consistent with the appearance of cyclopofol, etc.

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA classification of anesthesia: grades I-II; preoperative examination showed that the heart, lung and kidney functions were basically normal; met the indications for partial liver resection; received general anesthesia.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Those who have undergone repeated hepatic portal obstruction for a cumulative duration of more than 25 minutes; those with severe underlying diseases such as hypertension and diabetes; those who are extremely obese or emaciated.

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase;Aspartate aminotransferase;Superoxide dismutase;Malondialdehyde;Glutathione;Interleukin - 6 ;Interleukin - 10 ;Tumor Necrosis Factor - a;

Countries

China

Contacts

Public ContactLi Guohua

The Second Affiliated Hospital of Shandong First Medical University

lghtyfy@163.com+86 538 623 6905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026